DILTIAZEM HYDROCHLORIDE INJECTION

The Defense Logistics Agency awarded a delivery order under contract SPE2DX-25-D-9822 to DMS Pharmaceutical Group Inc. (CAGE 1UNB0) for the supply of one unit of Diltiazem Hydrochloride Injection (NSN 6505015055281, NDC 00641-6014-10) at a total price of $44.60, with delivery scheduled for July 16, 2026. The item is to be shipped FOB destination to Electric Boat Corporation in North Stonington, Connecticut, or alternatively to a designated parcel post address in Groton, Connecticut, with parcel post strictly prohibited; all shipments must use the fastest traceable means to ensure product integrity. Packaging and labeling must include the NSN, manufacturer CAGE code (32655), and contract identification numbers as specified, although no specific MIL-STD requirements are detailed. The contractor is certified as a small business, small disadvantaged business, and women-owned small business, triggering associated reporting and compliance obligations under FAR and SBA regulations. Payment is to be processed through the Defense Finance and Accounting Service in Columbus, Ohio, using payment code SL4701 and accounting data identified as 97X4930 5CBX 001 2620 S33189, with invoicing presumably submitted via WAWF. Acceptance of the product occurs at the destination by the Government, with no tolerance permitted for quantity deviations from the single-line item order. The ordering officer is Lisa Quinn, and administrative support is provided by Jayne Do, though no COTR or COR is formally identified. While the contract references compliance with terms and conditions incorporated from the underlying basic contract, no specific FAR or DFARS clauses are listed in the available documentation, suggesting full clauses are incorporated by reference rather than reproduced. All certifications and representations made by the awardee are subject to post-award audit and verification.